Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis

View source ↗

Summary

A clinical trial update on the efficacy of tildrakizumab for difficult-to-treat areas of psoriasis (palmar, genital, scalp, plantar, and nails); the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ilumya (tildrakizumab)

Snippet

Sponsor: Clin4all | Conditions: Psoriasis Palmaris, Psoriasis Genital | Status: ACTIVE_NOT_RECRUITING